111 (YI) Income towards Parent Company (2017 - 2025)
111 (YI) reported Income towards Parent Company of -$2.2 million for Q4 2025, down 10.5% on a YoY basis from -$2.5 million in Q4 2024, and down 15914.29% sequentially from -$14000.0 in Q3 2025.
111 (YI) Income towards Parent Company (2017 - 2025) Analysis & Trends
111 (YI) has 9 years of Income towards Parent Company data on file, last reported at -$2.2 million in Q4 2025.
- For the quarter ending Q4 2025, Income towards Parent Company fell 10.5% year-over-year to -$2.2 million; the trailing twelve-month figure through Dec 2025 stood at -$6.4 million (down 4.1% YoY), and the FY2025 full-year result was -$8.1 million, down 31.87% from the prior year.
- Income towards Parent Company retreated to -$2.2 million in Q4 2025, from -$14000.0 in the prior quarter.
- In the past five years, Income towards Parent Company ranged from a high of -$14000.0 in Q3 2025 to a low of -$39.2 million in Q3 2021.
- A 5-year average of -$8.1 million and a median of -$5.6 million in 2022 frame the typical range for Income towards Parent Company.
- Across the five-year window, Income towards Parent Company plunged 263.85% in 2021 and jumped 99.21% in 2025, its largest moves.
- Tracing YI's Income towards Parent Company over 5 years: stood at -$13.1 million in 2021, then jumped by 49.42% to -$6.6 million in 2022, then declined by 25.35% to -$8.3 million in 2023, then jumped by 75.59% to -$2.0 million in 2024, then fell by 10.5% to -$2.2 million in 2025.
- Business Quant data shows YI's Income towards Parent Company at -$2.2 million in Q4 2025, -$14000.0 in Q3 2025, and -$2.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.24 Mn |
| Sep 30, 2025 | -14,000.00 |
| Jun 30, 2025 | -2.33 Mn |
| Mar 31, 2025 | -1.86 Mn |
| Dec 31, 2024 | -2.03 Mn |
| Sep 30, 2024 | -1.76 Mn |
| Jun 30, 2024 | -1.21 Mn |
| Mar 31, 2024 | -1.19 Mn |
| Dec 31, 2023 | -8.31 Mn |
| Sep 30, 2023 | -9.17 Mn |
| Jun 30, 2023 | -4.56 Mn |
| Mar 31, 2023 | -1.10 Mn |
| Dec 31, 2022 | -6.63 Mn |
| Sep 30, 2022 | -9.12 Mn |
| Jun 30, 2022 | -10.19 Mn |
| Mar 31, 2022 | -12.70 Mn |
| Dec 31, 2021 | -13.11 Mn |
| Sep 30, 2021 | -39.24 Mn |
| Jun 30, 2021 | -18.28 Mn |
| Mar 31, 2021 | -16.68 Mn |